131 related articles for article (PubMed ID: 10933044)
1. Early increases in breast tumor xenograft water mobility in response to paclitaxel therapy detected by non-invasive diffusion magnetic resonance imaging.
Galons JP; Altbach MI; Paine-Murrieta GD; Taylor CW; Gillies RJ
Neoplasia; 1999 Jun; 1(2):113-7. PubMed ID: 10933044
[TBL] [Abstract][Full Text] [Related]
2. Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy.
Theilmann RJ; Borders R; Trouard TP; Xia G; Outwater E; Ranger-Moore J; Gillies RJ; Stopeck A
Neoplasia; 2004; 6(6):831-7. PubMed ID: 15720810
[TBL] [Abstract][Full Text] [Related]
3. Detection of Treatment Response in Triple-Negative Breast Tumors to Paclitaxel Using MRI Cell Size Imaging.
Jiang X; McKinley ET; Xie J; Gore JC; Xu J
J Magn Reson Imaging; 2024 Feb; 59(2):575-584. PubMed ID: 37218596
[TBL] [Abstract][Full Text] [Related]
4. Molecular imaging with aquaporin-based reporter genes: quantitative considerations from Monte Carlo diffusion simulations.
Chowdhury R; Wan J; Gardier R; Rafael-Patino J; Thiran JP; Gibou F; Mukherjee A
bioRxiv; 2023 Jun; ():. PubMed ID: 37333205
[TBL] [Abstract][Full Text] [Related]
5. Time-dependent diffusivity and kurtosis in phantoms and patients with head and neck cancer.
Solomon E; Lemberskiy G; Baete S; Hu K; Malyarenko D; Swanson S; Shukla-Dave A; Russek SE; Zan E; Kim SG
Magn Reson Med; 2023 Feb; 89(2):522-535. PubMed ID: 36219464
[TBL] [Abstract][Full Text] [Related]
6. Quantifying Tumor Heterogeneity via MRI Habitats to Characterize Microenvironmental Alterations in HER2+ Breast Cancer.
Kazerouni AS; Hormuth DA; Davis T; Bloom MJ; Mounho S; Rahman G; Virostko J; Yankeelov TE; Sorace AG
Cancers (Basel); 2022 Apr; 14(7):. PubMed ID: 35406609
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of metronomic chemotherapy response using diffusion and dynamic contrast-enhanced MRI.
Baboli M; Winters KV; Freed M; Zhang J; Kim SG
PLoS One; 2020; 15(11):e0241916. PubMed ID: 33237905
[TBL] [Abstract][Full Text] [Related]
8. Diffusion-weighted imaging of the breast: current status as an imaging biomarker and future role.
Camps-Herrero J
BJR Open; 2019; 1(1):20180049. PubMed ID: 33178933
[TBL] [Abstract][Full Text] [Related]
9. Paclitaxel Promotes Tumor-Infiltrating Macrophages in Breast Cancer.
Shen J; Chen C; Li Z; Hu S
Technol Cancer Res Treat; 2020; 19():1533033820945821. PubMed ID: 32783527
[TBL] [Abstract][Full Text] [Related]
10. Water dynamics in MCF-7 breast cancer cells: a neutron scattering descriptive study.
Martins ML; Dinitzen AB; Mamontov E; Rudić S; Pereira JEM; Hartmann-Petersen R; Herwig KW; Bordallo HN
Sci Rep; 2019 Jun; 9(1):8704. PubMed ID: 31213625
[TBL] [Abstract][Full Text] [Related]
11. Apparent diffusion coefficient as an effective index for the therapeutic efficiency of brain chemoradiotherapy for brain metastases from lung cancer.
Liu K; Ma Z; Feng L
BMC Med Imaging; 2018 Sep; 18(1):30. PubMed ID: 30223786
[TBL] [Abstract][Full Text] [Related]
12. Dual Src and EGFR inhibition in combination with gemcitabine in advanced pancreatic cancer: phase I results : A phase I clinical trial.
Cardin DB; Goff LW; Chan E; Whisenant JG; Dan Ayers G; Takebe N; Arlinghaus LR; Yankeelov TE; Berlin J; Merchant N
Invest New Drugs; 2018 Jun; 36(3):442-450. PubMed ID: 28990119
[TBL] [Abstract][Full Text] [Related]
13. The distribution of the apparent diffusion coefficient as an indicator of the response to chemotherapeutics in ovarian tumour xenografts.
Tourell MC; Shokoohmand A; Landgraf M; Holzapfel NP; Poh PS; Loessner D; Momot KI
Sci Rep; 2017 Feb; 7():42905. PubMed ID: 28220831
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance-guided focused ultrasound for the treatment of painful bone metastases: role of apparent diffusion coefficient (ADC) and dynamic contrast enhanced (DCE) MRI in the assessment of clinical outcome.
Anzidei M; Napoli A; Sacconi B; Boni F; Noce V; Di Martino M; Saba L; Catalano C
Radiol Med; 2016 Dec; 121(12):905-915. PubMed ID: 27567615
[TBL] [Abstract][Full Text] [Related]
15. Integrative analysis of diffusion-weighted MRI and genomic data to inform treatment of glioblastoma.
Jajamovich GH; Valiathan CR; Cristescu R; Somayajula S
J Neurooncol; 2016 Sep; 129(2):289-300. PubMed ID: 27393347
[TBL] [Abstract][Full Text] [Related]
16. Early Detection of Treatment-Induced Mitotic Arrest Using Temporal Diffusion Magnetic Resonance Spectroscopy.
Jiang X; Li H; Zhao P; Xie J; Khabele D; Xu J; Gore JC
Neoplasia; 2016 Jun; 18(6):387-97. PubMed ID: 27292027
[TBL] [Abstract][Full Text] [Related]
17. Multi-site clinical evaluation of DW-MRI as a treatment response metric for breast cancer patients undergoing neoadjuvant chemotherapy.
Galbán CJ; Ma B; Malyarenko D; Pickles MD; Heist K; Henry NL; Schott AF; Neal CH; Hylton NM; Rehemtulla A; Johnson TD; Meyer CR; Chenevert TL; Turnbull LW; Ross BD
PLoS One; 2015; 10(3):e0122151. PubMed ID: 25816249
[TBL] [Abstract][Full Text] [Related]
18. Dynamic contrast enhanced MRI detects early response to adoptive NK cellular immunotherapy targeting the NG2 proteoglycan in a rat model of glioblastoma.
Rygh CB; Wang J; Thuen M; Gras Navarro A; Huuse EM; Thorsen F; Poli A; Zimmer J; Haraldseth O; Lie SA; Enger PØ; Chekenya M
PLoS One; 2014; 9(9):e108414. PubMed ID: 25268630
[TBL] [Abstract][Full Text] [Related]
19. Early changes in apparent diffusion coefficient as an indicator of response to sorafenib in hepatocellular carcinoma.
Zhao YL; Guo QQ; Yang GR; Wang QD
J Zhejiang Univ Sci B; 2014 Aug; 15(8):713-9. PubMed ID: 25091989
[TBL] [Abstract][Full Text] [Related]
20. Imaging across the life span: innovations in imaging and therapy for gynecologic cancer.
Xu-Welliver M; Yuh WT; Fielding JR; Macura KJ; Huang Z; Ayan AS; Backes FJ; Jia G; Moshiri M; Zhang J; Mayr NA
Radiographics; 2014; 34(4):1062-81. PubMed ID: 25019442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
